Frequently Asked Questions
The Transfection Market size will be worth USD 2,537.10 million by 2031 during the forecast period.
The Transfection Market growth rate is 9.6% during the forecast period.
The Rising Demand For Gene Therapy & Developing Biopharmaceutical Industry For Efficient Manufacturing are the growth drivers of the Transfection Market.
The type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel are the factors on which the Transfection Market research is based.
The major companies in the Transfection Market are Mirus Bio LLC. (U.S.), Promega Corporation (U.S.), Polyplus (France), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Lonza (Switzerland), MaxCyte. (U.S.), Altogen Biosystems (U.S.), SBS Genetech (China), FUJIFILM Irvine Scientific. (U.S.), Croda International Plc. (U.K.), PerkinElmer Inc. (U.S.), Cytiva (U.S.), Geno Technology Inc. (U.S.), R&D Systems, Inc. (U.S.), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN (Germany), OriGene Technologies, Inc. (U.S.).
